<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>OAR@UM Community:</title>
    <link>https://www.um.edu.mt/library/oar/handle/123456789/38691</link>
    <description />
    <pubDate>Tue, 07 Apr 2026 22:13:29 GMT</pubDate>
    <dc:date>2026-04-07T22:13:29Z</dc:date>
    <item>
      <title>Torsade de Pointes : a diagnostic pitfall</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/840</link>
      <description>Title: Torsade de Pointes : a diagnostic pitfall
Authors: Tilney, Myra Kay; Galea Debono, Anthony
Abstract: Torsade de pointes is an unusual arrhythmia which is found in certain well defined clinical situations. The authors present two cases of Torsade de pointes which were admitted on two consecutive days, where the diagnosis was not immediately appreciated. It is important that one should become familiar with the E.C.G. appearance and be aware of the possible aetiology so that appropriate treatment can be initiated.</description>
      <pubDate>Mon, 01 Jan 1990 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/840</guid>
      <dc:date>1990-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Screening for coronary heart disease</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/817</link>
      <description>Title: Screening for coronary heart disease
Authors: Borg, Anton
Abstract: Malta and the United Kingdom share the dubious distinction of being among the three countries with the highest mortality rate from Cardiovascular disease in Europe; other countries in the Mediterranean basin have much lower rates. This presentation deals with a screening clinic for men carried out in the English West Country market town of Cirencester (population 16,000). The aim is a mass assault on risk factors for coronary heart disease, and results at the end of the first year suggest that, given sufficient opportunity and information, people are willing to be screened and to alter their lifestyle to reduce their level of risk of developing coronary disease.</description>
      <pubDate>Mon, 01 Jan 1990 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/817</guid>
      <dc:date>1990-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Schizophrenia : hope from emerging technologies</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/717</link>
      <description>Title: Schizophrenia : hope from emerging technologies
Authors: Orr, Michael
Abstract: The impact of two emerging technologies (brain imaging and molecular genetics) on the understanding of schizophrenia, and the extent to which advances in the understanding of the disorder have been reflected in advances in treatment or an alteration in the prognosis are reviewed. Treatment of schizophrenia still relies heavily on partly substantiated neurochemical hypotheses about the role of neurotransmitters in the genesis or expression of schizophrenic symptoms. These treatments have had little effect on the prognosis of the more severe types of schizophrenia. Brain imaging techniques and molecular genetics may however offer fresh insights into the nature and transmission of the disorder which could lead to advances in early recognition and prevention, and to radically new ways of classifying psychiatric disorders.</description>
      <pubDate>Mon, 01 Jan 1990 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/717</guid>
      <dc:date>1990-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Recent advances in cardiovascular medicines : thrombolytics</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/709</link>
      <description>Title: Recent advances in cardiovascular medicines : thrombolytics
Authors: Gatt, Marise; Felice, Herbert; Harron, Dean
Abstract: Thrombolytic therapy represents a major advance in reducing mortality following myocardial infarction. Pharmacists must be aware of the principles and problems of thrombolysis and the extant large studies conducted in hospitals and in the community. This article describes the various use and medicinal aspects of the various thrombolytic agents available on the market.</description>
      <pubDate>Mon, 01 Jan 1990 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/709</guid>
      <dc:date>1990-01-01T00:00:00Z</dc:date>
    </item>
  </channel>
</rss>

